Scrofula Caused by Multidrug-Resistant Tuberculosis

Detalhes bibliográficos
Autor(a) principal: Pedro, B
Data de Publicação: 2020
Outros Autores: Alves, L, Magano, R, Nunes, T, Marques, N
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.10/2467
Resumo: Tuberculosis (TB) is one of the top 10 causes of death worldwide. Multidrug-resistant tuberculosis (MDR-TB) occurs when at the minimum there is resistance to isoniazid and rifampin. Prevention of new infections of Mycobacterium tuberculosis and progression to TB disease is critical to reduce the burden and mortality of this disease. We present the case of a 73-year-old human immunodeficiency virus (HIV)-negative female who presented with cervical lymphadenopathy and who was diagnosed with MDR-TB. LEARNING POINTS: Tuberculosis is one of the most important causes of morbidity and mortality worldwide and approximately a quarter of the world's population is estimated to be latently infected by Mycobacterium tuberculosis.Multidrug-resistant tuberculosis lymphadenitis is a rare manifestation of the disease in Portugal.With the advent of multidrug-resistant tuberculosis, disease surveillance by the government should be intensified, with the aim of national and global TB control, focusing on prevention.
id RCAP_9ff251f63a94469c110290d8bf621201
oai_identifier_str oai:repositorio.hff.min-saude.pt:10400.10/2467
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Scrofula Caused by Multidrug-Resistant TuberculosisMycobacterium tuberculosisTuberculosisAntitubercular agentsExtensively drug-resistant tuberculosisTuberculosis (TB) is one of the top 10 causes of death worldwide. Multidrug-resistant tuberculosis (MDR-TB) occurs when at the minimum there is resistance to isoniazid and rifampin. Prevention of new infections of Mycobacterium tuberculosis and progression to TB disease is critical to reduce the burden and mortality of this disease. We present the case of a 73-year-old human immunodeficiency virus (HIV)-negative female who presented with cervical lymphadenopathy and who was diagnosed with MDR-TB. LEARNING POINTS: Tuberculosis is one of the most important causes of morbidity and mortality worldwide and approximately a quarter of the world's population is estimated to be latently infected by Mycobacterium tuberculosis.Multidrug-resistant tuberculosis lymphadenitis is a rare manifestation of the disease in Portugal.With the advent of multidrug-resistant tuberculosis, disease surveillance by the government should be intensified, with the aim of national and global TB control, focusing on prevention.SMC MediaRepositório do Hospital Prof. Doutor Fernando FonsecaPedro, BAlves, LMagano, RNunes, TMarques, N2020-07-08T11:50:58Z2020-01-01T00:00:00Z2020-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.10/2467engEur J Case Rep Intern Med. 2020 Jan 2;7(1):0013902284-259410.12890/2020_001390info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-20T15:53:08Zoai:repositorio.hff.min-saude.pt:10400.10/2467Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:53:22.660320Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Scrofula Caused by Multidrug-Resistant Tuberculosis
title Scrofula Caused by Multidrug-Resistant Tuberculosis
spellingShingle Scrofula Caused by Multidrug-Resistant Tuberculosis
Pedro, B
Mycobacterium tuberculosis
Tuberculosis
Antitubercular agents
Extensively drug-resistant tuberculosis
title_short Scrofula Caused by Multidrug-Resistant Tuberculosis
title_full Scrofula Caused by Multidrug-Resistant Tuberculosis
title_fullStr Scrofula Caused by Multidrug-Resistant Tuberculosis
title_full_unstemmed Scrofula Caused by Multidrug-Resistant Tuberculosis
title_sort Scrofula Caused by Multidrug-Resistant Tuberculosis
author Pedro, B
author_facet Pedro, B
Alves, L
Magano, R
Nunes, T
Marques, N
author_role author
author2 Alves, L
Magano, R
Nunes, T
Marques, N
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Hospital Prof. Doutor Fernando Fonseca
dc.contributor.author.fl_str_mv Pedro, B
Alves, L
Magano, R
Nunes, T
Marques, N
dc.subject.por.fl_str_mv Mycobacterium tuberculosis
Tuberculosis
Antitubercular agents
Extensively drug-resistant tuberculosis
topic Mycobacterium tuberculosis
Tuberculosis
Antitubercular agents
Extensively drug-resistant tuberculosis
description Tuberculosis (TB) is one of the top 10 causes of death worldwide. Multidrug-resistant tuberculosis (MDR-TB) occurs when at the minimum there is resistance to isoniazid and rifampin. Prevention of new infections of Mycobacterium tuberculosis and progression to TB disease is critical to reduce the burden and mortality of this disease. We present the case of a 73-year-old human immunodeficiency virus (HIV)-negative female who presented with cervical lymphadenopathy and who was diagnosed with MDR-TB. LEARNING POINTS: Tuberculosis is one of the most important causes of morbidity and mortality worldwide and approximately a quarter of the world's population is estimated to be latently infected by Mycobacterium tuberculosis.Multidrug-resistant tuberculosis lymphadenitis is a rare manifestation of the disease in Portugal.With the advent of multidrug-resistant tuberculosis, disease surveillance by the government should be intensified, with the aim of national and global TB control, focusing on prevention.
publishDate 2020
dc.date.none.fl_str_mv 2020-07-08T11:50:58Z
2020-01-01T00:00:00Z
2020-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.10/2467
url http://hdl.handle.net/10400.10/2467
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Eur J Case Rep Intern Med. 2020 Jan 2;7(1):001390
2284-2594
10.12890/2020_001390
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv SMC Media
publisher.none.fl_str_mv SMC Media
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130400615825408